Close Menu

NEW YORK (GenomeWeb News) – BGI has partnered with GENNET, a Prague-based center for genetics, fetal medicine, and assisted reproduction, to offer its non-invasive fetal trisomy test, NIFTY, in the Czech and Slovak Republics.

The NIFTY test uses next-generation sequencing to analyze maternal plasma for fetal aneuploidies including trisomy 21, trisomy 13, and trisomy 18, which cause Down syndrome, Patau syndrome, and Edwards syndrome, respectively.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.